ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Bausch Health Companies (BHC.TO)
Bausch Health Companies stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Toronto Stock Exchange · Canada
CA$8.87▼ -0.34%
Prices as of Oct 27, 2026 · CAD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bausch Health Companies in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bausch Health Companies
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Bausch Health Companies a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$7.78 and CA$9.84; in 9 out of 10, between CA$6.33 and CA$12.11. Estimated annual volatility is 72%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CA$3.1B
- Market cap (USD)
- $2.2B
- 52-week high
- CA$11.08
- 52-week low
- CA$6.10
- Revenue (12 months)
- $10.9B
- Gross margin
- 71.8%
- Operating margin
- 27.2%
- Net margin
- -10.1%
- Beta
- 0.37
What this means
ATLAS does not publish a fair value for BHC.TO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BHC.TO has traded between CA$6.10 and CA$11.08. Today it is 20.0% below that high and 45% above its low.
Its beta is 0.37: it tends to move less than the market.
About the company
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Want to see everything about Bausch Health Companies?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Bausch Health Companies do?
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
What is the chance BHC.TO goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, BHC.TO ends the month between CA$7.78 and CA$9.84.
How big is Bausch Health Companies and what is its P/E ratio?
Bausch Health Companies's market capitalization is CA$3.1B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is BHC.TO?
ATLAS estimates annual volatility at 72%. In a typical month, half of the outcomes end between CA$7.78 and CA$9.84.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer